Is it time to rethink the Alzheimer's disease drug development strategy by targeting its silent phase?
| Image |  |
|---|---|
| Description | scientific article |
| Author/s | |
| Publication date | February 1, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |